CORINNOVA INC

HOUSTON, TX · Medtech · Private

Implantable device that improves heart relaxation and function in diastolic heart failure patients

Claim this profile

Follows are private to you and power your alerts

Updated · corinnova.com

Sector
Medtech
Headquarters
HOUSTON, TX
Latest Form D
$350K, Jul 2017
Total capital
$1.6M
Federal grants
$1.2M
2 awards · 2019–2021
Rank in peer group#394 of 477
Private capital raised
$350K
1 Form D · last Jul 2017
112 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
1 pending

Capital timeline

20172018201920202021FEDERAL ↑EQUITY ↓Cumulative $1.6M$225K$994K1st Form D$350K
20172018201920202021FEDERAL ↑EQUITY ↓Cumulative $1.6M$225K$994K1st Form D$350K

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II:Minimally invasive device for restoration of ventricular diastolic recoil without blood contact$994K
  • Federal grantNSF · Phase I · SBIR Phase I: Non-blood contacting, less invasive device for restoration of ventricular diastolic recoil$225K
  • Private capital raisedForm D · SEC · 1st filing$350K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Boris LeschinskyExecutive OfficerNamed in SEC Form D filings
  • Clarice MotterExecutive OfficerNamed in SEC Form D filings
  • Dennis RobinsDirectorNamed in SEC Form D filings
  • John CriscioneDirectorNamed in SEC Form D filings
  • Keith SvagerkoExecutive OfficerNamed in SEC Form D filings
  • Michael TinerDirectorNamed in SEC Form D filings
Show all 7 people
  • William AltmanExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 1
  • PendingDirect Cardiac Compression Device with Improved DurabilityUSPTOApplication 62910037
  • CORINNOVA, INC.Shares a founder: Christina M Bolch
  • I-FUNCTION, INC.Similar federal contract value in Medtech · null in contracts
  • Ion Dx, Inc.Similar federal contract value in Medtech · null in contracts
  • Medicool TechnologiesSimilar federal contract value in Medtech · null in contracts
  • ONEBREATH, INC.Similar federal contract value in Medtech · null in contracts
  • RESUTURE INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .